280 related articles for article (PubMed ID: 11441303)
41. Estrogen deprivation therapy and colon cancer risk in breast cancer patients.
Malaka DO; Olopade OI
Breast J; 2010; 16(1):110-2. PubMed ID: 19929891
[No Abstract] [Full Text] [Related]
42. One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?
Sautter-Bihl ML; Sauer R
Strahlenther Onkol; 2007 Jul; 183(7):357-9. PubMed ID: 17609867
[No Abstract] [Full Text] [Related]
43. [Current trends in the treatment of primary breast cancer].
Letiagin VP
Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
[No Abstract] [Full Text] [Related]
44. Balancing the risks and benefits of extended adjuvant endocrine therapy.
Jhaveri KL
Clin Adv Hematol Oncol; 2019 Feb; 17(2):105-108. PubMed ID: 30845113
[No Abstract] [Full Text] [Related]
45. [Recent advance in adjuvant therapy for breast cancer].
Shimizu C; Watanabe T
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
[TBL] [Abstract][Full Text] [Related]
46. Preoperative chemotherapy and breast-conserving therapy: why not everyone?
Recht A
J Clin Oncol; 1997 Jul; 15(7):2479-82. PubMed ID: 9215815
[No Abstract] [Full Text] [Related]
47. Primary cutaneous marginal zone lymphoma as a complication of radiation therapy: Case report and review.
Breton AL; Poulalhon N; Balme B; Thomas L; Dalle S
Dermatol Online J; 2010 Dec; 16(12):6. PubMed ID: 21199632
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant systemic therapy of breast cancer.
Lippman ME
Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744
[No Abstract] [Full Text] [Related]
49. Adjuvant hormonal therapy for premenopausal women with breast cancer.
Brown RJ; Davidson NE
Semin Oncol; 2006 Dec; 33(6):657-63. PubMed ID: 17145345
[TBL] [Abstract][Full Text] [Related]
50. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Johansen J; Overgaard J; Overgaard M
Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
[TBL] [Abstract][Full Text] [Related]
51. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
52. Ovarian ablation as adjuvant therapy for early-stage breast cancer.
Pritchard KI
Cancer Treat Res; 1998; 94():158-80. PubMed ID: 9587687
[No Abstract] [Full Text] [Related]
53. [Adjuvant!Online--an Internet-based decision tool for adjuvant chemotherapy in early breast cancer].
Hess V
Ther Umsch; 2008 Apr; 65(4):201-5. PubMed ID: 18622911
[TBL] [Abstract][Full Text] [Related]
54. [Strategies of breast cancer treatment based on determination of biological subtype].
Semiglazov VF
Vopr Onkol; 2011; 57(5):542-52. PubMed ID: 22238922
[No Abstract] [Full Text] [Related]
55. [Treatment of breast cancer: from hormones to antibodies].
Eucker J; Emde A; Possinger K
Internist (Berl); 2006 Dec; 47(12):1223-4, 1226-8. PubMed ID: 17063333
[TBL] [Abstract][Full Text] [Related]
56. [Neoadjuvant systemic therapy in breast cancer].
Kahán Z; Nikolényi A; Uhercsák G; Thurzó L
Orv Hetil; 2009 Jan; 150(2):65-71. PubMed ID: 19103557
[TBL] [Abstract][Full Text] [Related]
57. [Current status of treatment for early-stage invasive breast cancer].
Kásler M; Polgár C; Fodor J
Orv Hetil; 2009 May; 150(22):1013-21. PubMed ID: 19465349
[TBL] [Abstract][Full Text] [Related]
58. Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.
Biganzoli L; Aapro M
Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):137-42. PubMed ID: 15990438
[TBL] [Abstract][Full Text] [Related]
59. [Comparison of the effectiveness of various comprehensive treatments for locally advanced breast cancer].
Kharchenko VP; Khmelevskiĭ EV; Panyshin GA
Vopr Onkol; 1998; 44(4):443-6. PubMed ID: 9807210
[TBL] [Abstract][Full Text] [Related]
60. Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
Balduzzi A; Montagna E; Bagnardi V; Torrisi R; Bertolini F; Mancuso P; Scarano E; Viale G; Veronesi P; Cardillo A; Orlando L; Goldhirsch A; Colleoni M
Anticancer Drugs; 2009 Mar; 20(3):197-203. PubMed ID: 19182679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
